Who owns DAY ONE BIOPHARMACEUTICALS I?
- Ticker: DAWN
- CUSIP Number: 23954d109
Tip: Access positions for across all investors
Analyze quarterly positions in Day One Biopharmaceuticals I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Day One Biopharmaceuticals I stock
Who bought or sold DAY ONE BIOPHARMACEUTICALS I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| State Street Corporation | 2.9M | $62M | -33% | Mar 2026 |
|
| Morgan Stanley | 687k | $15M | -56% | Mar 2026 |
|
| Henderson Group | 546k | $12M | 100% | Mar 2026 |
|
| Citigroup | 244k | $5.2M | 100% | Mar 2026 |
|
| T. Rowe Price Associates | 119k | $2.6M | 16% | Mar 2026 |
|
| CWM | 25k | $537k | 199% | Mar 2026 |
|
| Mirae Asset Global Investments | 5.4k | $116k | 8% | Mar 2026 |
|
| Bullock Wealth Management Group | 1.4k | $31k | 0% | Mar 2026 |
|
| IFP Advisors | 165.00 | $3.6k | -74% | Jun 2026 |
|
| Sunbelt Securities | 66.00 | $1.4k | 0% | Mar 2026 |
|